Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Innovative Industrial Properties

Visa

These high-growth stocks are fully capable of shrugging off any recessionary concerns.

3 Growth Stocks You'll Want to Own When the Next Recession Strikes

Vertex Pharmaceuticals

These titans of the healthcare sector sport virtual monopolies in their core markets.

2 Top Healthcare Stocks Every Investor Should Own

Apple

Cummins

Diamondback Energy

Alphabet

Lululemon Athletica

NIKE

Rollins

SVB Financial Group

While Lululemon’s done a great job taking the battle to its bigger opponent, there’s no question that Nike still has what it takes to ring up sales on the register.

10 Stocks to Buy Regardless of Q3 Earnings

Intuitive Surgical announced its quarterly earnings on October 17, and investors may be tempted to take gains after shares continue to climb.

Does Intuitive Surgical Have Room to Run After Earnings?

Intuitive Surgical generates its revenues primarily from sales of robotic surgical systems, and its related accessories & services.

Intuitive Surgical’s Revenue Growth Could Slow?

Despite avoiding this sector, it's home to a company with an impenetrable moat.

The No-Brainer Stock Warren Buffett Should Buy Right Now

The number of da Vinci robots in operation keeps climbing, supporting one powerful metric.

New Robots and Recurring Sales Push Intuitive Surgical Even Higher

Intuitive Surgical A Buy On Continuing Rapid Growth

Intuitive Surgical (ISRG) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Intuitive Surgical (ISRG) Catches Eye: Stock Jumps 7%

The robotic surgery specialist is only just getting started.

3 Key Takeaways From Intuitive Surgical's Monster Third Quarter

Sure, procedures were up -- but these factors are just as important.

The 3 Biggest Takeaways From Intuitive Surgical's Impressive Quarter

Intuitive Surgical, Inc. (NASDAQ: ISRG) shares are sharply higher Friday following strong quarterly results.

Analysts Constructive On Intuitive Surgical Following Solid Quarter

Intuitive Surgical (ISRG) gains from solid segmental contributions in Q3.

Intuitive Surgical (ISRG) Beats on Q3 Earnings, View Solid

Intuitive Surgical, Inc. (ISRG) CEO Gary Guthart on Q3 2019 Results - Earnings Call Transcript

Intuitive Surgical (ISRG) earnings for the company's third quarter of 2019 has ISRG stock taking off in after-hours trading Thursday.

Intuitive Surgical Earnings: ISRG Stock Soars 4% After Blowing Past Q3 Estimates

Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base. However, margin contraction continues to raise concern.

Here's Why You Should Retain Intuitive Surgical for Now

Better-than-expected performance at Instruments & Accessories segment and da Vinci procedure growth are likely to aided Intuitive Surgical (ISRG) in Q3 earnings.

What's in Store for Intuitive Surgical (ISRG) in Q3 Earnings?

ABB Ltd.

Cognex

FANUC Corp

iRobot

Rockwell Automation

Siemens AG

Zebra Technologies

Let's take a closer look at the largest robotics stocks available for your investment portfolio and why you should give these diverse companies some consideration.

The 10 Biggest Robotics Stocks

This medical innovator is quietly working on artificial intelligence technology that could pay off nicely for investors.

Here's a Great AI Stock You Might Be Overlooking

Robot-assisted surgery has momentum, and the pioneer of the industry is in great shape.

Where Will Intuitive Surgical Be in 5 Years?

Accuray

Medtronic

Stereotaxis Inc

Stryker

Varian Medical Systems

Accuray and Stereotaxis are hyper-focused on growth.

High-Tech Robotic Surgery Gets Specialized

There are plenty of reasons to invest in the robotic surgical systems stock. This one might surprise you.

A Compelling yet Counterintuitive Reason to Buy Intuitive Surgical Stock Right Now

Netflix

These three growth stocks will be worth watching when they report their third-quarter results.

Earnings: 3 Stocks to Watch This Month

Intuitive Surgical’s stock price has grown 60% over the last two years or so, led by growth in revenues and expansion of earnings multiple, partly offset by a slight decline in net income margin. In this note we discuss these factors that impacted Intuitive Surgical’s share price over the years.

What Led To 60% Growth In Intuitive Surgical’s Stock Over The Last Two Years?

FactSet Research Systems

Waters

When it comes to the economic moat, the installed base is relatively a new concept compared with brands, scale advantage, and the network effect.

News for Intuitive Surgical Stock (ISRG)